Table 3 Characteristics of study group and matched control group
RA (+) NTM-PD (N = 18) | RA (-) NTM-PD (N = 90) | P-value | |
|---|---|---|---|
Age, years, median (IQR) | 68 (59–73) | 68 (60–73) | 0.830 |
Female, N (%) | 16 (88.9) | 80 (88.9) | > 0.999 |
Body mass index, median (IQR) | 20.6 (16.2–21.3) | 20.0 (18.0–21.0) | 0.642 |
Comorbidities, N (%) | |||
History of tuberculosis | 2 (11.1) | 336 (40.0) | 0.028 |
Diabetes | 3 (16.7) | 5 (5.6) | 0.127 |
Chronic obstructive pulmonary disease | 0 | 4 (4.4) | 0.999 |
Malignancy | 0 | 11 (12.2) | 0.205 |
Presence of cavity, N (%) | 6 (33.3) | 30 (33.3) | > 0.999 |
AFB smear positivity, N (%) | 4 (22.2) | 23 (25.6) | > 0.999 |
M. avium complex, N (%) | 16 (88.9) | 77 (85.6) | > 0.999 |
Administration of anti-mycobacterial treatment, N (%) | 10 (55.6%) | 50 (55.6) | > 0.999 |
Microbiological cure, N (%) | 5/10 (50.0%) | 26/50 (53.1%) | > 0.999 |